Example of Multiple Sclerosis Journal format
Recent searches

Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format Example of Multiple Sclerosis Journal format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

Multiple Sclerosis Journal — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Neurology (clinical) #26 of 343 up up by 13 ranks
Neurology #14 of 156 up up by 11 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 875 Published Papers | 8298 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 21/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 7.3
SJR: 1.684
SNIP: 1.763
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 6.8
SJR: 1.651
SNIP: 1.671
open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.3
SJR: 1.395
SNIP: 2.063
open access Open Access

Bentham Science

Quality:  
High
CiteRatio: 6.0
SJR: 1.032
SNIP: 0.896

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

5.412

4% from 2018

Impact factor for Multiple Sclerosis Journal from 2016 - 2019
Year Value
2019 5.412
2018 5.649
2017 5.28
2016 4.84
graph view Graph view
table view Table view

9.5

9% from 2019

CiteRatio for Multiple Sclerosis Journal from 2016 - 2020
Year Value
2020 9.5
2019 8.7
2018 7.4
2017 7.6
2016 7.8
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 4% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 9% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.729

6% from 2019

SJR for Multiple Sclerosis Journal from 2016 - 2020
Year Value
2020 1.729
2019 1.837
2018 1.742
2017 1.668
2016 2.076
graph view Graph view
table view Table view

1.739

11% from 2019

SNIP for Multiple Sclerosis Journal from 2016 - 2020
Year Value
2020 1.739
2019 1.56
2018 1.341
2017 1.302
2016 1.359
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 6% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 11% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Multiple Sclerosis Journal

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Multiple Sclerosis Journal

Multiple Sclerosis Journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. Topics covered include: Clinical neurology, Myelin chemistry, N...... Read More

i
Last updated on
21 Jul 2020
i
ISSN
1352-4585
i
Impact Factor
High - 1.416
i
Acceptance Rate
35%
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys Rev B 1982; 25(7): 4515–4532.

Top papers written in this journal

Journal Article DOI: 10.1177/135245859900500409
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment:
J. S. Fischer1, Richard A. Rudick, Gary Cutter, Stephen C. Reingold

Abstract:

Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales such as the EDSS are inadequate in their assessment of key clinical dimensions of MS (e.g. , cognitive function), and they have psychometric limitations as well. Based o... Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales such as the EDSS are inadequate in their assessment of key clinical dimensions of MS (e.g. , cognitive function), and they have psychometric limitations as well. Based on analyses of pooled data from natural history studies and from placebo groups in clinical trials, the National MS Society's Clinical Outcomes Assessment Task Force recently proposed a new multidimensional clinical outcome measure, the MS Functional Composite (MSFC). The MSFC comprises quantitative functional measures of three key clinical dimensions of MS: leg function/ambulation, arm/hand function, and cognitive function. Scores on component measures are converted to standard scores (z-scores), which are averaged to form a single MSFC score. Preliminary analyses confirm that: (1) the three clinical dimensions of the MSFC are relatively independent; (2) the MSFC is sensitive to clinical changes over 1- and 2-year intervals; and (3) the MSFC has acceptable criterion validity (i.e., predicts both concurrent and subsequent EDSS change). The advantages and potential limitations of incorporating quantitative functional outcome measures such as the MSFC into collaborative databases are discussed. read more read less

Topics:

Multiple sclerosis functional composite (54%)54% related to the paper
855 Citations
Journal Article DOI: 10.1177/1352458513484547
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

Abstract:

Background: There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which pr... Background: There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope. Objective: The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders. Methods: Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey. Results: Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey. Conclusions: These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research. read more read less

Topics:

Clinically isolated syndrome (52%)52% related to the paper, Acute disseminated encephalomyelitis (50%)50% related to the paper
830 Citations
Journal Article DOI: 10.1177/135245859900500206
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
D. Matusevicius1, P. Kivisäkk1, Bing He1, Nikolaos Kostulas1, Volkan Özenci1, Sten Fredrikson1, Hans Link1

Abstract:

Myelin-directed autoimmunity is considered to play a key role in the pathogenesis of multiple sclerosis (MS). Increased production of both pro- and anti-inflammatory cytokines is a common finding in MS. Interleukin-17 (IL-17) is a recently described cytokine produced in humans almost exclusively by activated memory T cells, w... Myelin-directed autoimmunity is considered to play a key role in the pathogenesis of multiple sclerosis (MS). Increased production of both pro- and anti-inflammatory cytokines is a common finding in MS. Interleukin-17 (IL-17) is a recently described cytokine produced in humans almost exclusively by activated memory T cells, which can induce the production of proinflammatory cytokines and chemokines from parenchymal cells and macrophages. In situ hybridisation with synthetic oligonucleotide probes was adopted to detect and enumerate IL-17 mRNA expressing mononuclear cells (MNC) in blood and cerebrospinal fluid (CSF) from patients with MS and control individuals. Numbers of IL-17 mRNA expressing blood MNC were higher in patients with MS and acute aseptic meningoencephalitis (AM) compared to healthy individuals. Higher numbers of IL-17 mRNA expressing blood MNC were detected in MS patients examined during clinical exacerbation compared to remission. Patients with MS had higher numbers of IL-17 mRNA expressin... read more read less

Topics:

Proinflammatory cytokine (55%)55% related to the paper, Peripheral blood mononuclear cell (54%)54% related to the paper, Cytokine (53%)53% related to the paper, Interleukin 17 (53%)53% related to the paper, Chemokine (51%)51% related to the paper
802 Citations
open accessOpen access Journal Article DOI: 10.1177/1352458520970841
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.

Abstract:

Background:High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) ... Background:High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) ... read more read less
View PDF
702 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Multiple Sclerosis Journal.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Multiple Sclerosis Journal format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Multiple Sclerosis Journal in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Multiple Sclerosis Journal guidelines and auto format it.

2. Do you follow the Multiple Sclerosis Journal guidelines?

Yes, the template is compliant with the Multiple Sclerosis Journal guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Multiple Sclerosis Journal?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Multiple Sclerosis Journal citation style.

4. Can I use the Multiple Sclerosis Journal templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Multiple Sclerosis Journal.

5. Can I use a manuscript in Multiple Sclerosis Journal that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Multiple Sclerosis Journal that you can download at the end.

6. How long does it usually take you to format my papers in Multiple Sclerosis Journal?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Multiple Sclerosis Journal.

7. Where can I find the template for the Multiple Sclerosis Journal?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Multiple Sclerosis Journal's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Multiple Sclerosis Journal's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Multiple Sclerosis Journal an online tool or is there a desktop version?

SciSpace's Multiple Sclerosis Journal is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Multiple Sclerosis Journal?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Multiple Sclerosis Journal?”

11. What is the output that I would get after using Multiple Sclerosis Journal?

After writing your paper autoformatting in Multiple Sclerosis Journal, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Multiple Sclerosis Journal's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Multiple Sclerosis Journal?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Multiple Sclerosis Journal. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Multiple Sclerosis Journal?

The 5 most common citation types in order of usage for Multiple Sclerosis Journal are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Multiple Sclerosis Journal?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Multiple Sclerosis Journal's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Multiple Sclerosis Journal in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Multiple Sclerosis Journal Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Multiple Sclerosis Journal formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template